Catalytic activity: (2S) -2-methylacyl-CoA = (2R) -2-methylacyl-CoA. ,Disease:Defects in AMACR are the cause of alpha-methylacyl-CoA racemase deficiency (AMACRD) [MIM:604489]. AMACRD results in elevated plasma concentrations of pristanic acid C27-bile-acid intermediates. It can be associated with polyneuropathy , retinitis pigmentosa , epilepsy. ,Disease:Defects in AMACR are the cause of congenital bile acid synthesis defect type 4 (CBAS4) [MIM:214950]; also known as cholestasis , intrahepatic , with defective conversion of trihydroxycoprostanic acid to cholic acid or trihydroxycoprostanic acid in bile. Clinical features include neonatal jaundice , intrahepatic cholestasis , bile duct deficiency and absence of cholic acid from bile. ,Function:Racemization of 2-methyl-branched fatty acid CoA esters. Responsible for the conversion of pristanoyl-CoA and C27-bile acyl-CoAs to their (S) -stereoisomers. ,pathway:Lipid metabolism; bile acid biosynthesis. ,pathway:Lipid metabolism; fatty acid metabolism. ,similarity:Belongs to the caiB/baiF CoA-transferase family. ,similarity:Contains 1 C1q domain. ,similarity:Contains 1 collagen-like domain. ,
展开内容